Real-world outcomes from treating adults with moderate-to-severe atopic dermatitis with dupilumab are similar to what researchers have found in clinical trials, according to this study.
What were the treatment trends of 2018 according to ASDS research? Joely Kaufman, M.D., chair of the ASDS survey work group, explains.
With 4 decades of dermatology advances, we asked the very dermatologist experts who we often contact to help us to report on the milestones to weigh in on what they think have made the most difference in theirs and their patients’ lives.
Bioidentical hormones have been shown to decrease and prevent the risk of Alzheimer’s, osteoporosis and heart disease, which parallels the increased risk that comes with aging. Should you be offering HRT to your patients?
Bioidentical hormones have been shown to increase skin hydration and reduce skin atrophy. Dr. Ronald Moy discusses the benefits — and the hormones themselves — in the context of the aesthetic practice.
Over the past 40 years, there have been major dermatological breakthroughs that have changed the way doctors treat patients, along with the very treatments they use.
A small study examines platelet-rich plasma injection as alternative or adjuvant melasma treatment.
Patients with pigmentary disorders suffer high frequency of psychological disturbances, including anxiety and depression.
New options may be possible for treatment-resistant and severe rosacea with the use of IL-17 inhibitors as researchers conduct studies on effectiveness.
Today, the U.S. Food and Drug Administration approved the topical retinoid trifarotene 0.005% (AKLIEF, Galderma) for the treatment of acne vulgaris.